ARCHIVES

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

This article is from The Cancer Letter archive.

Vol. 12 No. 23 | June 6, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

CCOP Pink Sheets Go Out, Details Starting to Emerge On Number Of Awards, Payline, Possible Exceptions

May 6, 1983

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007